Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Tender notice |
| Buyer: | East Midlands Pharmacy Collaborative |
| Main Category: | Services |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | £2,760,000 |
Pipeline status
Not addedContract imported automatically · AI writes the response
Application Deadline
11 October 2024
Closed
Estimated Value
£2,760,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Release Date: | 9 August 2024 |
| Application Deadline: | 11 October 2024 |
| Procurement ID (OCID): | ocds-b5fd17-5cd8071a-3278-4ebf-83b8-949969b7a2b4 |
| Notice Reference: | 3c9e77db-fbc6-4358-be86-bda4a1084f20-776026 |
View Original Notice
Access the full notice on the official portal
This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk